Innovative X-ray and Radar Technology Reduces Risks in Cancer Screening

A new multimodal imaging method combining X-ray and radar technologies promises safer, more accurate early cancer detection with significantly lower radiation exposure.
Recent advancements in medical imaging are paving the way for safer and more accurate cancer detection methods. Researchers from the Fraunhofer-Gesellschaft have developed a pioneering approach that combines traditional X-ray imaging with radar technology to minimize radiation exposure during diagnosis and monitoring of breast and lung cancers.
While X-ray mammography remains the standard for early breast cancer detection due to its speed and precision, it involves exposure to ionizing radiation. High doses from more advanced imaging like CT scans pose health risks, especially with repeated use. To address this, the Fraunhofer team is exploring a multimodal imaging system that merges X-ray data with radar signals, which are well-known outside the medical field for their applications in aviation and automotive industries.
Radar offers a low-risk alternative to obtain three-dimensional images by detecting differences in tissue electrical properties without radiation. Despite lower resolution compared to X-ray, radar can reveal vital tissue changes, especially when integrated correctly with other imaging methods. The team is working on sophisticated algorithms to accurately align (or 'co-register') radar and X-ray data, enhancing the clarity and detail of internal tissue visualization.
This approach involves developing special imaging phantoms—artificial models mimicking human tissue—to test and optimize the combined system. The goal is to create a comprehensive, multimodal lab setup capable of early detection of tissue abnormalities with high precision and reduced radiation dose.
This innovative method not only aims to improve diagnostic accuracy but also significantly reduces the physical and health burden on patients. In a three-year project, the research team envisions a future where cancer screening is safer, more effective, and less invasive.
Source: https://medicalxpress.com/news/2025-08-ray-radar-technology-combined-cancer.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Long-Term Results Confirm Safety and Effectiveness of Zigakibart in Treating IgA Nephropathy
Extended 100-week data confirms that zigakibart is a safe and effective treatment option for IgA nephropathy, showing sustained proteinuria reduction and stable kidney function.
Blood Stem Cell Mutations and Their Potential Role in Reducing Alzheimer's Disease Risk
Research reveals that mutations in blood stem cells, particularly in the TET2 gene, may significantly reduce the risk of late-onset Alzheimer's disease by enhancing brain immune responses.
U.S. Restrictions on COVID-19 Boosters Raise Concerns Among Patients and Experts
New U.S. regulatory restrictions on COVID-19 booster shots raise concerns among patients and health experts about increased risks and reduced vaccine access amid ongoing pandemic challenges.
Low Uptake of RSV Antibody Shots in Infants Highlights Disparities
A new study reveals low coverage of RSV antibody shots among eligible infants, with significant disparities affecting marginalized groups, highlighting the need for improved vaccination efforts and equity.



